ROYCE & ASSOCIATES LP - ANACOR PHARMACEUTICALS INC ownership

ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 204 filers reported holding ANACOR PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of ANACOR PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2015$6,609,000
-53.0%
58,500
-51.0%
0.04%
-48.0%
Q3 2015$14,066,000
+13.9%
119,500
-25.1%
0.08%
+44.2%
Q2 2015$12,350,000
-25.0%
159,500
-43.9%
0.05%
-16.1%
Q1 2015$16,458,000
+49.9%
284,500
-16.4%
0.06%
+63.2%
Q4 2014$10,981,000
+31.8%
340,5000.0%0.04%
+35.7%
Q3 2014$8,332,000340,5000.03%
Other shareholders
ANACOR PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 5,621,423$59,700,00036.62%
VHCP Management, LLC 1,610,856$17,107,0009.45%
Broadfin Capital, LLC 1,737,669$18,454,0003.28%
Consonance Capital Management LP 737,685$7,834,0001.96%
Palo Alto Investors LP 1,600,178$16,994,0001.78%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 520,091$5,523,0001.06%
QVT Financial LP 1,358,303$14,425,0000.98%
Lombard Odier Asset Management (USA) Corp 1,700,000$18,054,0000.91%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,702,300$18,061,0000.89%
Perceptive Advisors 1,947,736$20,684,0000.85%
View complete list of ANACOR PHARMACEUTICALS INC shareholders